First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication (Q47666650)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication |
scientific article |
Statements
1 reference
First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication (English)
1 reference
Steven Lemery
1 reference
Patricia Keegan
1 reference
Richard Pazdur
1 reference
1 October 2017
1 reference
377
1 reference
15
1 reference
1409-1412
1 reference